Transgenic analysis of the role of FKBP12.6 in cardiac function and intracellular calcium release

Assay and Drug Development Technologies

Volumn 9, Issue 6, 2011, Pages 620-627

  Liu, Ying ^a,b   Chen, Hanying ^b   Ji, Guangju ^c   Li, Baiyan ^b,d   Mohler, Peter J ^e   Zhu, Zhiming ^b,f   Yong, Weidong ^b   Chen, Zhuang ^b   Xu, Xuehong ^b   Xin, Hongbo ^a   Shou, Weinian ^b  

^a SICHUAN UNIVERSITY   (China)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF BIOPHYSICS   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

^e OHIO STATE UNIVERSITY   (United States)

^f THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; MYOSIN HEAVY CHAIN ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ELECTROCARDIOGRAM; EXERCISE; FEMALE; GENE OVEREXPRESSION; HEART ARRHYTHMIA; HEART DEVELOPMENT; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HISTOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; SUDDEN DEATH;

ANIMALS; CALCIUM; CARDIOMEGALY; FEMALE; HUMANS; INTRACELLULAR FLUID; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCYTES, CARDIAC; TACROLIMUS BINDING PROTEINS;

EID: 83055178342     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2011.0411     Document Type: Article

References (31)

1. Wehrens XH, Lehnart SE, Marks AR: Intracellular calcium release and cardiac disease. Annu Rev Physiol 2005;67:69-98. (Pubitemid 40404486)
2. Snyder SH, Sabatini DM: Immunophilins and the nervous system. Nat Med 1995;1:32-37.
3. Timerman AP, Onoue H, Xin HB, et al.: Selective binding of FKBP12.6 by the cardiac ryanodine receptor. J Biol Chem 1996;271:20385-20391. (Pubitemid 26281806)
4. Jeyakumar LH, Ballester L, Cheng DS, et al.: FKBP binding characteristics of cardiac microsomes from diverse vertebrates. Biochem Biophys Res Commun 2001;281:979-986. (Pubitemid 32923058)
5. Guo T, Cornea RL, Huke S, et al.: Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks. Circ Res 2010;106:1743-1752.
6. Bassing CH, Shou W, Muir S, Heitman J, Matzuk MM, Wang XF: FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes. Cell Growth Differ 1998;9:223-228. (Pubitemid 28354302)
7. Xin HB, Senbonmatsu T, Cheng DS, et al.: Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 2002;416:334-338.
8. Wehrens XH, Lehnart SE, Huang F, et al.: FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exerciseinduced sudden cardiac death. Cell 2003;113:829-840. (Pubitemid 36792028)
9. Maruyama M, Li BY, Chen H, et al.: FKBP12 is a critical regulator of the heart rhythm and the cardiac voltage-gated sodium current in mice. Circ Res 2011;108:1042-1052.
10. Masumiya H, Wang R, Zhang J, Xiao B, Chen SR: Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2f release channel (ryanodine receptor). J Biol Chem 2003;278:3786-3792. (Pubitemid 36801105)
11. Zissimopoulos S, Lai FA: Interaction of FKBP12.6 with the cardiac ryanodine receptor C-terminal domain. J Biol Chem 2005;280:5475-5485. (Pubitemid 40280023)
12. Xiao B, Sutherland C, Walsh MP, Chen SR: Protein kinase A phosphorylation at serine-2808 of the cardiac Ca2f-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6). Circ Res 2004;94: 487-495. (Pubitemid 38326284)
13. Jin JP, Walsh MP, Sutherland C, Chen W: A role for serine-175 in modulating the molecular conformation of calponin. Biochem J 2000;350 Pt 2:579-588.
14. Danila CI, Hamilton SL: Phosphorylation of ryanodine receptors. Biol Res 2004;37:521-525.
15. Xu X, Su B, Barndt RJ, et al.: FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506. Transplantation 2002;73:1835-1838. (Pubitemid 34655263)
16. Chen H, Yong W, Ren S, et al.: Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth. J Biol Chem 2006;281:27481-27491. (Pubitemid 44401775)
17. Wu G, Toyokawa T, Hahn H, Dorn GW, 2nd. Epsilon protein kinase C in pathological myocardial hypertrophy. Analysis by combined transgenic expression of translocation modifiers and Galphaq. J Biol Chem 2000;275:29927-29930.
18. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR: Nucleic Acids Res 2001;29:e45.
19. Mitchell GF, Jeron A, Koren G: Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol 1998;274(3 Pt 2):H747-751.
20. Mohler PJ, Schott JJ, Gramolini AO, et al.: Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003;421: 634-639. (Pubitemid 36227671)
21. Arai M, Matsui H, Periasamy M: Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 1994;74:555-564. (Pubitemid 24088516)
22. Dorn GW, 2nd, Robbins J, Sugden PH: Phenotyping hypertrophy: eschew obfuscation. Circ Res 2003;92:1171-1175. (Pubitemid 36723642)
23. Rodriguez P, Kranias EG: Phospholamban: a key determinant of cardiac function and dysfunction. Arch Mal Coeur Vaiss 2005;98:1239-1243.
24. Luo J, McMullen JR, Sobkiw CL, et al.: Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol 2005;25:9491-9502. (Pubitemid 41507849)
25. McMullen JR, Shioi T, Zhang L, et al.: Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci USA 2003;100:12355-12360. (Pubitemid 37271564)
26. Gulick J, Subramaniam A, Neumann J, Robbins J: Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 1991;266:9180-9185. (Pubitemid 21906635)
27. Xiao RP, Valdivia HH, Bogdanov K, Valdivia C, Lakatta EG, Cheng H: The immunophilin FK506-binding protein modulates Ca2f release channel closure in rat heart. J Physiol 1997;500(Pt 2):343-354. (Pubitemid 27193071)
28. Gellen B, Fernandez-Velasco M, Briec F, et al.: Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation 2008;117:1778-1786. (Pubitemid 351507466)
29. Marx SO, Ondrias K, Marks AR: Coupled gating between individual skeletal muscle Ca2f release channels (ryanodine receptors). Science 1998;281: 818-821. (Pubitemid 28376041)
30. Ondrias K, Marx SO, Gaburjakova M, Marks AR: FKBP12 modulates gating of the ryanodine receptor/calcium release channel. Ann N Y Acad Sci 1998;853:149-156. (Pubitemid 28515037)
31. Su Z, Sugishita K, Li F, Ritter M, Barry WH: Effects of FK506 on [Ca2f[i differ in mouse and rabbit ventricular myocytes. J Pharmacol Exp Ther 2003;304: 334-341. (Pubitemid 36008946)